AccessPak for HIV PEP Expanded with Kaletra and Ganirelix Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Ganirelix Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ganirelix
Brand name: Antagon, Ganirelix Acetate
Synonyms: Ganirelix
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Ganite
- AccessPak for HIV PEP Expanded with Kaletra-Gantrisin
- AccessPak for HIV PEP Expanded with Kaletra-Gantrisin Pediatric
- AccessPak for HIV PEP Expanded with Kaletra-Garamycin
- AccessPak for HIV PEP Expanded with Kaletra-Garamycin Injection
- AccessPak for HIV PEP Expanded with Kaletra-Garamycin Topical
- Ganirelix Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Ganirelix Subcutaneous-Accolate
- Ganirelix Subcutaneous-Accretropin
- Ganirelix Subcutaneous-Accucaine
- Ganirelix Subcutaneous-AccuHist Drops
- Ganirelix Subcutaneous-AccuHist PDX Drops